Moleculin Biotech, Inc.
MBRX
$2.43
$0.020.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -182.59% | 144.39% | -358.59% | -29.40% | 10.33% |
| Total Depreciation and Amortization | -11.11% | -59.09% | -21.43% | -9.68% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.53% | -177.35% | 1,146.77% | 292.21% | 42.22% |
| Change in Net Operating Assets | -39.81% | 210.86% | -405.97% | -147.45% | -32.50% |
| Cash from Operations | -13.88% | 25.71% | -29.40% | -22.30% | 10.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.56% | 17.57% | 17.55% | -32.20% | 799,800.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.67% | 17.44% | 17.55% | -32.20% | 799,800.00% |
| Foreign Exchange rate Adjustments | -214.81% | 1,000.00% | -- | -100.00% | 106.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.84% | 354.68% | -437.11% | -104.62% | 167.06% |